Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | Diseases of the Kidney & Urinary Tract
What is the purpose of this trial?
The purpose of this study is to determine the efficacy and safety of ALLN-177 in patients with enteric hyperoxaluria
- Ages18 years and older
- Trial withAllena Pharmaceuticals, Inc.
- Start Date06/28/2019
- End Date07/31/2019
- Last Updated07/15/2021
- Study HIC#2000024788